Director/PDMR Shareholding

Dechra Pharmaceuticals PLC
21 December 2007


                           DECHRA PHARMACEUTICALS PLC

                                 (the Company)


                             Director Shareholding


The Company has been informed that Michael Redmond, a Director of the Company,
has today acquired 6,475 ordinary shares of 1p each ('Ordinary Shares') in the
Company at a price of 357.5p per share.


Michael Redmond's beneficial interest in the Company is now 41,475 Ordinary
Shares, which represents approximately 0.078 per cent. of the Company's issued
ordinary share capital.


Pursuant to the Company's Placing and Open Offer (announced on 12 December 2007)
Michael Redmond confirmed his intention to take up his entitlement under the
said offer. For tax structuring reasons it has not been possible to procure that
the trust holding Michael Redmond's shareholding take up his entitlement.


Michael Redmond has therefore today purchased shares in the open market,
equivalent in value to his entitlement under the Company's Placing and Open
Offer, in order to fulfil the intention, stated within the Prospectus.



21 December 2007



                      This information is provided by RNS
            The company news service from the London Stock Exchange
       SOKDKNABDDNBB